Phreesia Joins Call to Action to Improve Adult Vaccination Rates
23 Gennaio 2024 - 12:40PM
Business Wire
Phreesia, a leader in patient intake, outreach and activation,
is pleased to announce that it has joined the National Adult and
Influenza Immunization Summit’s Call to Action for Adult
Immunizations campaign to improve adult vaccination rates.
More than three in four adults are missing routinely recommended
vaccines and, due to preventive care put on hold during the
COVID-19 pandemic, low vaccination rates have worsened. The mission
of the campaign is to encourage healthcare providers to take action
to improve the implementation of adult vaccination recommendations
to protect adults from preventable illness, disability and death.
The campaign has 45 organizations in support of the call to action,
including Adult Vaccine Access Coalition, American Medical
Association (AMA), American Pharmacists Association (APhA),
National Forum for Heart Disease and Stroke Prevention and National
Foundation for Infectious Diseases (NFID).
"We're thrilled to be part of this call to action that gives
preventive care, like getting recommended immunizations, the
importance it deserves,” said Alicia Cowley, MD, Director of
Clinical Content at Phreesia. “Supporting patients in taking a more
active role in their care and giving them the resources they need
to make informed decisions is at the heart of what we do at
Phreesia, and we're so proud of our work to help more adults get
vaccinated.”
Phreesia’s vaccine management tools support healthcare
organizations by collecting critical information, engaging patients
about immunizations, and saving staff time. Within the last few
years, Phreesia has delivered over 20.7 million messages to adults
to encourage conversations with care teams about recommended
vaccines.
According to a survey conducted on the Phreesia platform, over
31% of respondent patients exposed to these messages found the
information mostly or all new, and over 35% were very or extremely
likely to ask their doctor about the vaccine. As a result of these
solutions, Phreesia has helped healthcare organizations increase
immunization rates for the following vaccines: Influenza;
Pneumococcal; Human papillomavirus (HPV); Shingles; Tetanus,
diphtheria and pertussis (Tdap); COVID-19 and Respiratory syncytial
virus (RSV).
In a January 12 editorial in the Annals of Internal Medicine
about the need for better communication to help address low
immunization rates, the authors pointed to Phreesia’s platform as
an example of a tool that goes beyond simply informing
patients.
“We need innovative solutions to foster shared decision making,”
the authors said in the editorial. “Phreesia, a company that
engages with patients in more than 1 in 10 of all U.S. health care
appointments, modified its patient interface to promote adult
vaccination at the ‘touch point’ of a medical visit. This effort
resulted in 20 million patient prompts for recommended adult
vaccines. In a follow-up survey, one third of [respondent] patients
indicated their intent to get vaccinated.”
For more information about Phreesia, visit www.phreesia.com.
About Phreesia Phreesia is
the trusted leader in patient activation, giving providers, health
plans, life sciences companies and other organizations tools to
help patients take a more active role in their care. Founded in
2005, Phreesia enabled more than 120 million patient visits in
2022–more than 1 in 10 visits across the U.S.–scale that we believe
allows us to make meaningful impact. Offering patient-driven
digital solutions for intake, outreach, education and more,
Phreesia enhances the patient experience, drives efficiency and
improves healthcare outcomes. To learn more, visit
www.phreesia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240123504199/en/
Media Nicole Gist
Nicole.Gist@phreesia.com 407-760-6274
Grafico Azioni Phreesia (NYSE:PHR)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Phreesia (NYSE:PHR)
Storico
Da Giu 2023 a Giu 2024